3-RTA Triple Agonist Research Documentation

Research-use-only scope: This page documents the BioPep USA product record and available certificates of analysis. It does not provide preparation, dosing, injection, human-use, animal-use, therapeutic, diagnostic, cosmetic, or clinical guidance.

BioPep USA lists 3-RTA Triple Agonist under the catalog name 3-RTA Triple Agonist. The product record lists 10mg, 15mg, and 30mg single vials. Select the number of vials on the product page.

Current product record

  • BioPep USA catalog name: 3-RTA Triple Agonist
  • Current sizes: 10mg, 15mg, and 30mg
  • Quantity: Single vials; set the number of vials on the product page
  • Product page: 3-RTA Triple Agonist

Available 3-RTA Triple Agonist COAs

Three lot records in the BioPep USA COA library match the three sizes currently listed on the product page.

  • 10mg – Lot BU-8620700-P: 99.43% purity; analyzed May 10, 2026. Open COA PDF.
  • 15mg – Lot BU-7575305-P: 99.36% purity; analyzed May 6, 2026. Open COA PDF.
  • 30mg – Lot BU-1857910-P: 99.42% purity; analyzed May 7, 2026. Open COA PDF.

How the names relate

3-RTA Triple Agonist is a BioPep USA catalog label, not the name of a scientific publication. Match the exact product, lot number, and vial size to the PDF; a catalog label alone does not establish chemical identity or suitability for human or animal use.

Record-check sequence

  1. Confirm the desired size on the current product page.
  2. Match that size to a lot in the COA library.
  3. Check the lot number, purity value, and analysis date on the PDF.

What this page does not provide

COAs document a tested lot. They do not provide administration, preparation, dosing, expected outcomes, or medical guidance. For a lot-specific question, contact BioPep USA and include the lot number shown on the record.

Last reviewed: September 15, 2026.